営業外費用計、Accumulated Depreciation Buildings And Structures、有形固定資産の取得による支出他2件
- 【期間】
| 年度 | 営業外費用計 | Accumulated Depreciation Buildings And Structures | 有形固定資産の取得による支出 | Investment Securities | Capital Expenditures Overview Of Capital Expenditures Etc - Pharmaceutical Products Reportable Segments Member |
|---|
| 2009/12 | 262百万 | | - | | -11.6億 | | - | | - | |
| 2010/12 | 236百万 | -9.9% | - | | -14.5億 | 赤拡 | - | | - | |
| 2011/12 | 142百万 | -39.8% | - | | -10.9億 | 赤縮 | - | | - | |
| 2012/12 | 42百万 | -70.4% | - | | - | | - | | - | |
| 2013/12 | 40百万 | -4.8% | - | | - | | - | | - | |
| 2014/12 | 28百万 | -30% | - | | - | | - | | - | |
| 2015/12 | 28百万 | ±0% | - | | - | | - | | - | |
| 2016/12 | 105百万 | +275% | - | | - | | - | | - | |
| 2017/12 | 77百万 | -26.7% | - | | - | | - | | - | |
| 2018/12 | 396百万 | +414.3% | - | | - | | - | | - | |
| 2019/12 | 60百万 | -84.8% | - | | - | | - | | - | |
| 2020/12 | 55百万 | -8.3% | - | | - | | - | | - | |
| 2021/12 | 101百万 | +83.6% | - | | - | | - | | - | |
| 2022/12 | 52百万 | -48.5% | - | | - | | - | | - | |
| 2023/12 | 131百万 | +151.9% | - | | - | | - | | - | |
